Stockscreener 앱 받기
7.97
3.39%
-0.28
Maplight Therapeutics Inc 주식(MPLT)의 최신 뉴스
MapLight Therapeutics’ Kreitzer sells $96,024 in common stock By Investing.com - Investing.com South Africa
MapLight Therapeutics CMO Erin Foff sells $124,068 in stock By Investing.com - Investing.com South Africa
Form 4 MapLight Therapeutics Inc: James Woodruff Lillie (Chief Scientific Officer) For: 15 October - Investing.com Nigeria
MapLight Therapeutics CMO Erin Foff sells $124,068 in stock - Investing.com
MapLight Therapeutics chief scientific officer sells $93,025 in shares - Investing.com
MapLight Therapeutics general counsel reports $72,881 stock sale - Investing.com
MapLight Therapeutics CAO sells $82,149 in shares - Investing.com
MapLight Therapeutics’ Kreitzer sells $96,024 in common stock - Investing.com
MapLight Therapeutics CAO sells $82,149 in shares By Investing.com - Investing.com UK
MapLight Therapeutics chief scientific officer sells $93,025 in shares By Investing.com - Investing.com UK
Form 4 MapLight Therapeutics Inc: Anatol Kreitzer (Chief Discovery Officer) For: 15 October - Investing.com Nigeria
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com Nigeria
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com India
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com UK
MapLight Therapeutics Officer Christopher Kroeger Files to Sell 73,691 Shares to Cover RSU Tax Withholding - Kalkine Media
MapLight Therapeutics Officer Lillie James Woodruff to Sell 11,513 Shares for RSU Tax Withholding - Kalkine Media
MapLight Therapeutics Director Robert Malenka Announces Sale of 14,809 RSU Shares via Rule 144 - Kalkine Media
Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com - Investing.com Nigeria
Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com - Investing.com Australia
MapLight Therapeutics (MPLT) exec to sell shares under preset trading plan - stocktitan.net
MapLight Therapeutics, Inc. (MPLT) Stock Price Quote Today & Current Price Chart - Capital.com
MapLight Therapeutics to Participate in Upcoming Investor Conference - The Manila Times
BlackRock Inc. Takes $36.74 Million Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading Up 5.3%Here's What Happened - MarketBeat
Needham cuts MapLight Therapeutics price target on dilution concerns By Investing.com - Investing.com Canada
Needham cuts MapLight Therapeutics price target on dilution concerns By Investing.com - Investing.com India
Maplight Therapeutics (NASDAQ:MPLT) Price Target Lowered to $43.00 at Needham & Company LLC - MarketBeat
Freestone Grove Partners LP Makes New $6.05 Million Investment in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Nan Fung Group Holdings Ltd Makes New $34.81 Million Investment in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading Down 4.6%What's Next? - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading 7.8% HigherShould You Buy? - MarketBeat
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Segal Trials Reinforces Leadership in Acute Schizophrenia Research Following Participation in MapLight Therapeutics’ Phase 2 ZEPHYR Study - Business Wire
Blue Owl Capital Holdings LP Takes $26.16 Million Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
MPLT: MapLight Therapeutics, Inc.Financial Overview - Zacks Investment Research
MapLight Therapeutics (MPLT): Nan Fung group holds passive stake above 5% - Stock Titan
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Down 7%Should You Sell? - MarketBeat
MapLight Therapeutics (MPLT) grants CDO 24K options and 6K RSUs - stocktitan.net
MapLight (NASDAQ: MPLT) grants CEO 93,955 options and 23,145 RSUs - Stock Titan
MapLight Therapeutics (MPLT) grants CSO new options and RSUs - stocktitan.net
MapLight Therapeutics (MPLT) lifts GC stake with 31K options - stocktitan.net
MapLight (MPLT) Reported Results Review: The EPS Result Is Below Expectation in the Reported Period; Trading-Day Reaction: Shares Rise 5.11% in Latest TradingGuidance Downgrade Alert - Vinanet
Catalyst4 builds 49.9% MapLight (MPLT) stake in private share deal - Stock Titan
MapLight Therapeutics, Inc. (MPLT) - Zacks Investment Research
MapLight Therapeutics announces $150M private placement - TipRanks
Morgan Stanley Maintains MapLight Therapeutics(MPLT.US) With Hold Rating, Maintains Target Price $21 - Moomoo
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
LifeSci Capital Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Maintains Target Price $37 - Moomoo
BMO Capital Initiates MapLight Therapeutics(MPLT.US) With Buy Rating, Announces Target Price $20 - Moomoo
MapLight presses the pause button; ADC Therapeutics considers what to do with Zynlonta - Endpoints News
3.09%
0.72%
자본화:
|
볼륨(24시간):